TY  - GEN
AU  - Gozdas, Hasan Tahsin
AU  - Karabay, Oguz 
TI  - Reversible bilateral ototoxicity in a patient with chronic hepatitis B during peginterferon alpha-2a treatment
PY  - 2015///
CY  - Mumbai
PB  - Wolter Kluwer
KW  - PHARMACOLOGY
N2  - Peginterferon alpha-2a (PEG IFN α-2a) is frequently used in chronic hepatitis B (CHB)treatment. Numerous adverse events can be noted during this therapy such as flu-like disease, rash, weight loss and depression. However, PEG IFN α-2a related ototoxicity seems to be an uncommon entity. Ototoxicity can be detected objectively by audiometry. In this paper, we present a case of CHB who developed reversible bilateral ototoxicity during PEG IFN α-2a treatment. Due to ototoxicity detected objectively by audiogram, treatment was ceased at sixth month and ototoxicity completely recovered one month after stopping the drug
UR  - https://journals.lww.com/iphr/fulltext/2015/47010/reversible_bilateral_ototoxicity_in_a_patient_with.24.aspx
ER  -